NASDAQ:SLGL

Sol-gel Technologies Stock Insider Trading

Healthcare > Biotechnology

Buy SLGL

*Your capital is at risk

$71.50

-2.23 (-3.02%)

At Close: Jun 03, 2026

Sol-Gel Technologies Stock Insider Power

Based on the 64 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 432.46K and sold 0 SLGL shares in the last 64 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 64 transactions)	100.00
● Buy	432.46K shares
● Sell	0 shares
100% Buy Activity Weak Positive Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 20, 2026 Buy	Ordinary Shares, par value NIS 1.00 per share. P-Purchase	Opaleye Management Inc. 10 Percent Owner	10% Owner	1 563 Value: $100.7K
May 13, 2026 Buy	Ordinary Shares, par value NIS 1.00 per share. P-Purchase	Opaleye Management Inc. 10 Percent Owner	10% Owner	1 937 Value: $129.5K
May 12, 2026 Buy	Ordinary Shares, par value NIS 1.00 per share. P-Purchase	Opaleye Management Inc. 10 Percent Owner	10% Owner	1 500 Value: $102.0K
Mar 24, 2026 Buy	Ordinary Shares, par value NIS 1.00 per share. P-Purchase	Opaleye Management Inc. 10 Percent Owner	10% Owner	5 000 Value: $360.0K
Mar 24, 2026 Buy	Ordinary Shares, par value NIS 1.00 per share. P-Purchase	Opaleye Management Inc. 10 Percent Owner	10% Owner	34 665 Value: $2.50M
Mar 18, 2026 Buy	Stock Option (right to buy)	Ben-or Eyal Chief Financial Officer	C-Suite Officer	2 500 Value: $20.9K
Mar 18, 2026 Buy	Stock Option (right to buy)	Lerman Hanna Director	Director	2 031 Value: $113.0K
Mar 18, 2026 Buy	Stock Option (right to buy)	Gottfried Ran Director	Director	4 500 Value: $450.9K
Mar 18, 2026 Buy	Ordinary shares	Gottfried Ran Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Arkin Moshe Chairman Of Board And CEO	CEO / President	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Arkin Moshe Chairman Of Board And CEO	CEO / President	0 Value: $0
Mar 18, 2026 Buy	Stock Option (right to buy)	Toledano Ofer Vp Research & Dev.	Officer	1 000 Value: $9K
Mar 18, 2026 Buy	Stock Option (right to buy)	Toledano Ofer Vp Research & Dev.	Officer	8 487 Value: $475.3K
Mar 18, 2026 Buy	Stock Option (right to buy)	Toledano Ofer Vp Research & Dev.	Officer	7 615 Value: $761.5K
Mar 18, 2026 Buy	Stock Option (right to buy)	Toledano Ofer Vp Research & Dev.	Officer	4 460 Value: $248.2K
Mar 18, 2026 Buy	Stock Option (right to buy)	Toledano Ofer Vp Research & Dev.	Officer	712 Value: $11.3K
Mar 18, 2026 Buy	Ordinary Shares	Toledano Ofer Vp Research & Dev.	Officer	0 Value: $0
Mar 18, 2026 Buy	Stock Option (right to buy)	Levy-hacham Ofra Vp Clinical, Reg & Quality	Officer	1 000 Value: $9K
Mar 18, 2026 Buy	Stock Option (right to buy)	Levy-hacham Ofra Vp Clinical, Reg & Quality	Officer	6 790 Value: $380.2K
Mar 18, 2026 Buy	Stock Option (right to buy)	Levy-hacham Ofra Vp Clinical, Reg & Quality	Officer	6 092 Value: $609.2K
Mar 18, 2026 Buy	Stock Option (right to buy)	Levy-hacham Ofra Vp Clinical, Reg & Quality	Officer	3 568 Value: $198.6K
Mar 18, 2026 Buy	Stock Option (right to buy)	Levy-hacham Ofra Vp Clinical, Reg & Quality	Officer	569 Value: $9K
Mar 18, 2026 Buy	Stock Option (right to buy)	Glezin Michael Chief Business Officer	Officer	7 500 Value: $521.3K
Mar 18, 2026 Buy	Stock Option (right to buy)	Glezin Michael Chief Business Officer	Officer	5 000 Value: $44.8K
Mar 18, 2026 Buy	Stock Option (right to buy)	Yosef Itzik Chief Operating Officer	C-Suite Officer	2 031 Value: $203.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SOL-GEL TECHNOLOGIES LTD.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream ...

Read Full Profile Here